Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554110 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Stimulation to Reduce Hypoxic Events
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02554110: Completed NA study, sponsored by Mayo Clinic.
NCT02554110 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02554110, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
Interventions
- DEVICE Stimulator active device
- DEVICE Stimulator sham Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-10-12 |
| Est. Completion | 2017-01-19 |
| Phase | NA |
What the finished NCT02554110 record still lists
NCT02554110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Stimulator active device is the first listed.
NCT02554110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02554110 about?
NCT02554110 is a clinical study titled "Peripheral Nerve Stimulation to Reduce Hypoxic Events". This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
What is the current status of trial NCT02554110?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-10-12. Estimated completion is 2017-01-19.
What interventions are being tested in trial NCT02554110?
The interventions under investigation include: Stimulator active device (DEVICE), Stimulator sham Device (DEVICE).
Who is sponsoring clinical trial NCT02554110?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02554110's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI